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To reduce inferior vena cava filter (IVCF) related complications, retrieval is recommended whenever 
possible. Nevertheless, IVCF retrieval rates remain lower than expected, likely due to insufficient 
follow‑up after placement. We evaluated the value of a structured program designed to follow 
patients by the interventional radiology team up to 5 months after IVCF placement. We prospectively 
enrolled 366 consecutive patients (mean age 64 ± 17 years; 201 men and 165 women) who benefited 
from IVCF between March 2015 and February 2020. The program consisted of advising the patient 
and clinicians to consider IVCF retrieval as soon as possible (standard workflow) and systematically 
planning an additional follow‑up visit at 5‑month. Clinical and technical eligibility, as well as technical 
success for retrieval (TSR) were evaluated. At 5‑months, 38 (10.4%) patients were lost to follow‑up, 
and 47 (12.8%) had died. Among survivors, the overall retrieval rate was 58%. The retrieval rates were 
83% and 97% for the clinically eligible and technically eligible patients for retrieval, respectively. 
The 5‑month visit enabled 89 additional retrievals (47.8%) compared to the standard workflow. No 
significant difference was seen in TSR before and after 5 months (p = 0.95). Improved patient tracking 
with a dedicated IVCF program results in an effective process to identify suitable patients for retrieval 
and drastically improves retrieval rates in eligible patients. Involving interventionalists in the process 
improved IVCF patient management.
Inferior vena cava filters (IVCFs) have been widely used since the 1970s to prevent pulmonary embolism (PE) 
in patients with or without venous thromboembolic disease. Reportedly, up to 17% of patients with PE receive 
an  IVCF1. Despite their frequent use, the indications for, clinical benefits, and long-term outcomes of IVCF use 
are regularly a matter of debate and concern, resulting in non-standardized guidelines and sometimes conflict-
ing  recommendations2.
Recent systematic reviews and meta-analyses3,4 have shown that patients with an IVCF have a lower risk of 
recurrent PE, an increased risk of deep venous thrombosis (DVT), trend of lower PE-related mortality, and no 
change in short-term all-cause mortality. A recent study conducted in patients with cancer-associated venous 
thromboembolism who received an IVCF confirmed the absence of significantly different all-cause mortality, 
but showed a lower PE-related  mortality5. DVT is the most common complication, occurring in up to 20% of 
 patients6, even after early initiation of anticoagulation in patients with  IVCFs7. Moreover, IVCF use is associated 
with multiple mechanical complications, mostly with long-term  use3. These limitations justified the promotion 
of temporary filtration and retrieval of the filtration device as soon as possible. Optional IVCFs, which can be 
used either as retrievable or permanent filters, have been developed to overcome these  limitations8.
Despite the spread of optional IVCF use and recommendations for retrieval, low rates of effective filter 
retrieval have been observed. In recent literature, the IVCF retrieval rate ranges from 1 to 64%3,9–13, with a mean 
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of 34%3. The main reason is a lack of follow-up after filter placement and failure to inform patients regarding the 
benefits of retrieving the filter if  possible3,14.
Given the risk of adverse events associated with a long IVCF dwell time, retrieval plans and structured 
follow-up strategies are being established in many  hospitals14–17. Such approaches should allow definition of the 
conditions in which an optional filter can be retrieved and ensure that all filters eligible for retrieval are effectively 
retrieved. Several follow-up strategies have been proposed, and the key to successful follow-up and filter removal 
is the presence of one central actor, being the operator or his team. The operator is responsible for the IVCF 
implantation procedure, but also the follow-up after  insertion18,19. In other words, the operator’s team is in charge 
of informing both the patient and the referring clinician about the possibility and timing of retrieval, and to 
ensure that no filter is left in place without re-evaluating the situation. Following this rationale, we implemented 
a quality improvement program in the Department of Radiology to improve our practice.
The objective of the current study was to report our structured program for patient follow-up after IVCF 
placement and evaluate its impact on IVCF retrieval rate.
Materials and methods
The Cantonal Commission on Ethics in Human Research (CER-VD) approved this prospective study protocol. 
All procedures conducted by the Lausanne University Hospital under the Federal Act on Research involving 
Human Beings (Human Research Act, HRA). Informed consent was obtained from all participants.
Study design. The study was designed to prospectively include all patients referred to the Department of 
Radiology for IVCF placement between March 2015 and February 2020. At our institution, all IVCF place-
ment procedures are performed in the Department of Radiology. Since 2015, all patients have received the same 
optional IVCF (Denali; Bard Peripheral Vascular, Inc., Tempe) when indicated.
Inclusion criteria were age over 18 years, an indication for IVCF placement, and consent to be enrolled. 
Patients with a contraindication for placement of a Denali filter per the instructions for use (i.e., stenosis or 
compression of the inferior vena cava or an anatomic variant of the inferior vena cava system) and patients 
receiving peri-procedural pharmaco-mechanical thrombectomy for PE or DVT were excluded from the study.
Indications for IVCF placement are defined by the Standards of Practice of the Society of Interventional 
Radiology and separated into therapeutic (i.e., a thromboembolic event was documented) and prophylactic 
 categories18. By local multidisciplinary consensus, prophylactic indications are limited due to controversies 
about the benefit-risk  balance20.
The standard workflow at our institution incorporates a number of steps to maximize patient and clinician 
awareness regarding the need to remove the filter once it is not needed anymore:
1. Following IVCF placement and before discharge, the instructions for filter retrieval were documented as 
soon as possible in the medical report.
2. A copy of the medical report was sent to the patient’s primary care physician, including instructions encour-
aging a clinical visit with the IVCF IR referent whenever the filter was no longer needed.
3. The patient was informed of the strategy after IVCF placement.
Beyond that, the study consisted of adding a structured follow-up program as a refinement strategy to ensure 
that all subjects receive an assessment for potential filter retrieval (Fig. 1). To this end, we scheduled a systematic 
follow-up visit at 5 months; if the filter was removed early (before 5 months), the follow-up visit was cancelled. 
Clinical visits for follow-up were conducted centrally by a single member of the interventional radiology (IR) 
team (*blinded*) assigned to this task (IVCF referent). To balance the risks of irretrievability due to prolonged 
dwell time and simultaneously avoid redundant patient visits, the time to re-evaluation was set at 5 months.
When assessing the impact of the 5-month follow-up visit on filter retrieval, patients who had their IVCF 
removed early were considered to be part of the standard workflow, and those who completed the 5-month 
follow-up visit were considered as being part of the standard workflow + additional follow-up visit since they 
could potentially benefit from the refinement strategy. By design, any filter removal procedures performed after 
5 months reflect the impact of the additional follow-up visit provided by IRs on the IVCF retrieval rate.
Figure 1.  Prospective longitudinal study design. IVCF inferior vena cava filter, IR interventional radiologist.
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Filter placement procedure. Placement was performed using the standard technique from femoral, jugu-
lar or subclavian venous access under local anesthesia. First, phlebography of the inferior vena cava was per-
formed to locate the renal veins and estimate the diameter of the vena cava. The filter was then deployed under 
fluoroscopic guidance. The intended optimal position is immediately infra-renal, below the most caudal renal 
vein. In the case of an aberrant retro-aortic renal vein, the filter was placed below the most caudal right renal 
vein. If the filter was tilted (primary tilt) or malpositioned (primary malposition), no additional maneuvers were 
recommended, so the tilt or malposition was noted in the report.
Filter removal procedure. Criteria for filter removal included the clinical status and technical retriev-
ability of the filter as described in the outcome section. The procedure was planned on a day case basis and 
performed percutaneously by jugular venous access under local anesthesia. The filter was withdrawn under 
fluoroscopic guidance using a dedicated snare system (Bard). In the case of snaring failure, more advanced tech-
niques could be used at the radiologist’s discretion.
Outcome assessment. The primary endpoint was the retrieval rate in the standard workflow and standard 
workflow with additional 5-month follow-up visit, in eligible patients. Secondary endpoints were mechanical 
issues that compromise filter retrieval and complications during the retrieval procedure. Mechanical issues were 
categorized as filter tilt, penetration, migration or material embolization, fracture, and vena cava stenosis/occlu-
sion, as previously reported in the Standards of Practice of the Society of Interventional  Radiology18. Technical 
success for IVCF placement corresponded to successful optimal placement.
Clinical criteria for permanent filtration were based on life expectancy (< 6 months), age (> 90 years), antico-
agulation failure after re-introduction, long-term contraindication of anticoagulation, and long-term immobiliza-
tion. If, on the day of placement, the patient presented with at least one clinical criterion, the filter was declared 
permanent, and the 5-month visit canceled. Patients with no criteria for permanent filtration were considered 
clinically eligible for filter retrieval.
Technical filter retrievability assessment was performed with indirect CT venography, routinely obtained 
before evaluating patients for filter  retrieval21–23. Technical irretrievability was based on the presence of a large 
thrombus in the filter (> 30% of filter volume) or deep penetration. Filter tilt was not considered a criterion of 
irretrievability. Patients with no irretrievability criteria were considered technically eligible for retrieval. Patients 
who had a thrombus in the filter were treated with anticoagulant therapy and reassessed for possible retrieval. 
Technical success was defined as successful retrieval of the filter.
Procedural complications were registered and defined as minor (i.e., no consequences requiring hospitaliza-
tion > 23 h post-procedure) or major (i.e., supplementary stay from 1 day to a fatal event)18. Deaths during the 
5 months following IVCF placement were documented.
Statistical analysis. Statistical analysis was conducted using R 3.5.3 (R Core Team 2015). Continuous vari-
ables were expressed as mean ± standard deviation. Categorical variables were presented as absolute numbers 
and proportions and compared using the chi-squared or Fisher exact test as appropriate. Percentages were used 
to report the occurrence rate in each category. p < 0.05 were considered significant. Patients lost to follow-up or 
who had died were excluded from the analysis.
Results
Patient characteristics and IVCF placement. A total of 366 consecutive patients (201 men, 54.9%; 165 
women, 45.1%) were enrolled in the study. The mean age was 64 ± 17 years. The majority of patients had an IVCF 
placed for an absolute indication and simultaneous contra-indication for anticoagulation (62.3%), followed by 
complications of anticoagulation therapy (20.6%). The filters were also placed for relative indications of surgery 
planned for patients with thromboembolic disease (4.7%), inability to achieve or maintain a satisfactory anti-
coagulation level (2.4%), an iliocaval deep vein thrombosis (1.8%), or a recurrent deep vein thrombosis (1.2%). 
Prophylactic indications consisted of high risk for thromboembolic disease due to risk factors (4.1%) and severe 
trauma (2.9%; Table 1).
A total of 370 IVCFs were placed in 366 patients; 359 (97%) were placed in the infra-renal position. Four 
patients received a second filter placed several months (mean 862 ± 1176 days) after the first filter retrieval. All 
procedures for IVCF placement were successful, and no periprocedural complication was observed.
Follow‑up and filter retrieval. At 5 months, 38 (10.4%) patients were lost to follow-up, and 47 had died 
(12.8%). Thirty-two of the deaths (68%) occurred within 30 days. Thus, 281 patients were analyzed regarding 
IVCF retrieval.
A total of 150/281 (53.3%) patients benefited from early evaluation with retrieval (mean 48 ± 36 days), includ-
ing 105 before discharge (70%) and 45 (30%) during an early visit with the IVCF IR referent. The 5-month follow-
up strategy allowed to evaluate 131 (46.6%) more patients for filter retrieval. In 10 patients (3.5%), the IVCF 
was declared permanent at the time of placement. Among the clinically eligible patients, 12 (5.3%) refused the 
retrieval procedure. Overall, a total of 225/281 (80%) patients were clinically eligible for IVCF retrieval. In the 
standard workflow, 109/150 (72.6%) patients were found to be clinically eligible and 99/109 (90.8%) technically 
eligible for retrieval, whereas 116/131 (88.5%) patients who had 5-month follow-up were found clinically and 
92/116 (79.3%) technically eligible, p < 0.001 and 0.02, respectively. Reasons for technical ineligibility are detailed 
in Table 2. A process flowchart (Fig. 2) from patient enrollment to outcome is provided for clarity.
Technically successful retrieval was achieved in 186/191 (97.4%) patients. Among patients initially considered 
technically non-eligible, 13/225 (5.8%) had a thrombus inside the filter, 5 patients in the standard workflow, and 
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8 patients with 5-month follow-up. After anticoagulation therapy, six additional patients were re-categorized 
as eligible for retrieval, which was performed successfully in five of them. The overall technical success was 
not significantly different in the standard workflow (98%, 97/99) and in filters removed after the follow-up 
visit (96.7%, 89/92; p = 0.95). The complications leading technical ineligibility (thrombus and penetration) and 
failure (penetration or tilt) are reported in Table 3. All failed retrieval procedures were associated with at least 
one mechanical complication.
The overall retrieval rate was 50.8% (186/366). Among survivors, the overall retrieval rate was 66.2% 
(186/281). The retrieval rates at the end of the study were 82.7% (186/225) and 97.4% (186/191) for the clini-
cally eligible and technically eligible patient subsets, respectively. The dwell time before retrieval was 39.7 days 
in the standard workflow and 218.7 days in standard workflow with 5-month visit. The 5-month visit enabled 
retrieval in 89 additional patients (47.8%, 89/186) compared to the standard workflow, leading to a significantly 
higher overall retrieval rate Table 3. Figures 3, 4, and 5 show examples of patients seen at the 5-month follow-up 
visit who were clinically eligible but either technically non-eligible (Figs. 3 and 4), or technically eligible with 
retrieval failure (Fig. 5).  
Discussion
The rationale for temporary filtration is based on well-founded concerns regarding long-term complications of 
permanent IVCFs, particularly in young patients with a temporary contraindication for anticoagulation. This has 
led to the development of retrievable filters. Though the underlying purpose of retrieving unnecessary IVCFs is 
relevant, strategies for identifying patients suitable for IVCF removal still lack in broader practice, resulting in 
limited clinical impact. Therefore, the benefit of placing retrievable filters is questionable, and improvements in 
the process have to be considered.
Several studies investigating factors associated with low IVCF retrieval rates have pointed out poor patient fol-
low-up as the primary  reason10. Utilization of IVCFs and the subsequent retrieval rates vary widely by geography 
Table 1.  Demographic characteristics and indications of filter placement in the study population (survivors 
with 5 month follow-up). M men, W women, IVCF inferior vena cava filter, ACT anticoagulation therapy, PE 
pulmonary embolism, DVT deep venous thrombosis.
Standard workflow
Standard workflow +  
follow-up Total
Patients (n) 150 131 281
Age (years ± SD) 64 ± 18 63 ± 17 64 ± 17
Sex (M/W) 85/64 74/57 201/165
IVCF indication
Absolute
 PE and contraindication to ACT 147
 Proximal DVT and contraindication to ACT 56
 PE/DVT and complication of ACT 26
Relative
 Recurrent PE under ACT 12
 Recurrent DVT 6
 Inability to achieve adequate anticoagulation 8
 DVT and severe trauma 11
 Prophylactic
 High risk patients 15
Table 2.  Technical eligibility for IVCF retrieval in clinically eligible patients. IVCF inferior vena cava filter. 
a Volume thrombus within the filter more than 30%. b Patients with transmural deep penetration.
Standard workflow
Standard workflow + 
 5-month follow-up Total
Age (years) 79.6 65.5
Eligible 99/109 (90.8%) 92/116 (79.3%) 191/225 (84.9%)
Non-eligible 10/109 (9.2%) 24/116 (20.6%) 34/225 (15.1%)
Findings in technically non eligible patients
Thrombusa 5/10 (50%) 8/24 (33.3%) 13/34 (38.2%)
Penetrationb 1/10 (10%) 9 (37.5%) 10/34 (29.4%)
Tilt 4/10 (40%) 7/24 (29.2%) 7/34 (20.6%)
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and institution, suggesting that appropriate tracking of patients and specific recommendations for adequate 
follow-up would likely improve patient safety. Our study demonstrates that, from a clinical point of view, it is not 
reasonable to aim for retrieving IVCFs in all patients. For multiple reasons, the overall retrieval rate was ~ 51% 
in our study. However, a structured follow-up with the systematic 5-month visit concept provided a very high 
rate of retrievability, reaching 99% in eligible patients. The addition of a 5-month visit significantly improved the 
retrieval rate, as roughly half (48%) of the retrieval procedures were performed after the 5-month visit. These 
results are comparable or slightly better than those reported in the literature, mainly in retrospective reviews 
or comparisons. In the PREPIC2  study24, a randomized multicenter trial for retrievable IVCFs, more than 90% 
of IVCFs were removed because of a 3-month follow-up visit. Another study comparing retrieval rates for 100 
Figure 2.  Flowchart. Technically eligible patients (n = 191) include 6 patients initially deemed technically non-
eligible due to thrombus who received anticoagulant therapy and achieved technical eligibility.
Table 3.  Retrieval rates achieved at different stages of the study. *p value < 0.001. § p value < 0.001.
Patients n Filter retrieval rate (No.)
Overall population 366 51% (186)
Survivors 319 58% (186)
Survivors with 5-month follow-up 281 66% (186)
Standard workflow
All clinically eligible* 225 43% (97)
All technically eligible§ 191 51% (97)
Standard workflow with 5-month visit
Clinically eligible* 225 83% (186)
Technically eligible§ 191 97% (186)
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Figure 3.  Post-deployment subtracted cavography shows IVCF positioned in infrarenal position and absence of 
IVC stenosis, in a patient with femoral and iliac DVT under ACT (a); CT venography obtained 5 months later 
shows IVC stenosis on coronal reformatted image (b), and thrombus trapped inside the IVCF (c,d), leading to 
technical ineligibility for retrieval. ACT anticoagulation therapy, CT computed tomography, DVT deep venous 
thrombosis, IVC inferior vena cava, IVCF inferior vena cava filter.
Figure 4.  CT venography obtained one month after IVCF placement shows filter tilt and acute DVT of the iliac 
veins and infrarenal IVC on axial (a) and coronal reformatted image (b), leading to technical ineligibility for 
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temporary filters with and without IVCF clinic reported a substantial improvement, from 29% without to 60% 
with an IVCF  clinic25.
The time to a re-evaluation of IVCF retrievability may be a matter of discussion. The risk of non-retrievability 
increases with prolonged dwell  time20,26 and depends on the indication for placement. For example, a recent study 
showed that trauma patients have a retrieval rate twice as high as other  patients27 due to retrieval before discharge. 
In addition, complication rates have been reported to be higher 6 months after  placement28, discouraging lengthy 
follow-up delays. As the main indications at our institution were non-prophylactic, we designed the follow-up 
visit for 5 months to balance between benefits and risks, as it is far enough away from the placement to avoid 
recalling every patient and giving approximately a month to plan and complete the retrieval procedure within 
6 months. Our strategy of selecting 5 months seems appropriate regarding the technical success of retrieval, as 
no significant difference was found between early retrieval and retrieval after 5 months. Directly combining the 
scheduling of the 5-month visit with the IVCF placement report is a simple and effective means of following the 
patient and improving the quality control of the service provided. However, it is critical to inform the patient 
about the follow-up visit the day of placement to increase comprehension of the filter management process and 
decrease patient apprehension regarding further investigations. Centralizing all visits with the IVCF IR referent 
smoothes out the process and homogenizes patient management.
Interestingly, the rates of eligible patients for filter retrieval were similar in both patient subsets, which can be 
attributed to a systematic and thorough assessment of eligibility criteria by the IVCF IR referent for identifying 
suitable patients. Other alternatives have been reported. A multidisciplinary  team29 or a dedicated IVCF  clinic25 
are effective approaches that have shown promising results. However, they are more complex to implement.
Controversies regarding the use of retrievable IVCFs for each patient are justified due to a higher risk of 
complications than permanent filters when left in  place20,29–31. Nevertheless, the strategy of offering retrieval 
appeared to be more appropriate, as only 3.5% of the delivered filters were declared permanent at the time of 
placement. Deciding on permanent filtration at the time of deployment is problematic, as the majority of IVCFs 
are being placed in an emergency setting. In the present study, despite the effectiveness of a prospective follow-
up program, 33% of filters were left in place, and 5.8% were unsuccessfully retrieved. Therefore, considering 
Figure 5.  In a clinically eligible patient for IVCF retrieval, CT venography showed an embedded filter hook 
(a) due to a tilt visible both on sagittal (b) and coronal (c) reformatted images. Fluoroscopy image during the 
procedure shows unsuccessful attempt to retrieve the IVCF using a single-loop snare system (d). CT computed 
tomography, IVCF inferior vena cava filter.
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the long-term complication rates of retrievable filters, it is critical to select the appropriate filter for insertion. 
The MAUD database, in which IVCF-related adverse events are reported, clearly indicates that all filters are not 
 equal21. However, asymptomatic patients with unsuccessful IVCF retrieval and significant mechanical disorders 
(i.e., deep penetration or a tilt of more than 15°) rarely develop clinical  complications30.
One of the major factors associated with irretrievability of the filter was death before removal (13.1%). This 
is consistent with a recent systematic review analyzing reasons for non-retrieval31, in which the mortality was as 
high as 19.4%. In the same report, patient refusal was the reason for 2.4% of non-retrievals. In our study, patient 
refusal occurred in 5.3% of eligible patients, which represents 3.3% of the whole study population.
The present study has several limitations. Despite its prospective design, 10% of patients were lost to follow-
up. This is similar to the percentage (13%) recently reported by a systematic review on the utility of  IVCF31. Our 
institution is a tertiary center, and several patients were transferred from other centers for filter placement, mak-
ing it challenging to follow them after the procedure. Furthermore, the study did not integrate a cost-effectiveness 
analysis that may help us understand such follow-up programs’ financial impact. Finally, as designed, this study 
did not allow evaluation of long-term prognosis and the predictive value of demographic characteristics, filter 
dwell-time, and serological biomarkers for VTE recurrence and death. Conducting additional mid-term and 
long-term follow-up in a larger cohort is a relevant future perspective, intending to identify patients at increased 
risk of recurrent VTE.
In conclusion, improved patient tracking with a dedicated IVCF program results in an effective process for 
identifying suitable patients for retrieval and drastically improves retrieval rates in eligible patients. By imple-
menting well-organized and straightforward follow-up programs, the mission to avoid any potential long-term 
complications of these temporary devices and improve patient care may be fulfilled.
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